Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

This Phase 3 study tests nitazoxanide (NTZ)-based antibiotic combinations as a new treatment approach for Helicobacter pylori infection in children — a stomach bacterium that can cause ulcers and, if untreated, long-term digestive problems. Standard H. pylori treatments sometimes fail, and researchers are testing whether NTZ-based regimens offer a more effective alternative. Children with a confirmed positive Helicobacter pylori test who have not previously been treated for the infection are eligible. Participation involves taking the assigned antibiotic regimen and follow-up testing to check whether the infection was successfully cleared. This summary was prepared as patient-facing educational content using AI assistance.